Maxine Singer Named President Of Carnegie

WASHINGTON—Maxine Frank Singer, chief of the biochemistry laboratory at NIH's National Cancer Institute, has been named the next president of the Carnegie Institution of Washington. Singer, a molecular biologist, will succeed James Ebert, who has been president since 1978. Founded by Andrew Carnegie in 1902, the private, nonprofit Institution has an annual budget of $16 million. It supports research in biology, astronomy and the earth sciences by 60 scientists and 120 fellows at five cente

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Founded by Andrew Carnegie in 1902, the private, nonprofit Institution has an annual budget of $16 million. It supports research in biology, astronomy and the earth sciences by 60 scientists and 120 fellows at five centers in the United States and Chile.

"Carnegie stands for tremendous excellence in science," said Singer. "It has a reputation for breaking new ground in important areas of research, for being adventurous in what it is willing to support, and for being small enough to be flexible."

Singer, 56, will become the first woman to lead the institution when she assumes her position March 1, 1988. She said she hopes to continue her research at NIH on genome organization in primates. "I expect to have a lab here, but my office will be at Carnegie," she said, referring to the future swapping of her administrative duties as a lab chief for those of an institution ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies